CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that could balloon to $285 million if treble damages are imposed. The ruling stems from a False Claims Act lawsuit brought by whistleblower Sarah Behnke, a former actuary at Aetna, who accused CVS Caremark Corp. of artificially inflating drug prices submitted to CMS, while paying pharmacies like Rite Aid and Walgreens significantly less.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
